OHR Pharmaceutical Inc.

About OHR

OHR Pharmaceutical Pipeline

OHR is focused on the development of novel therapeutics for the treatment of serious and unmet medical needs.

Learn More

Latest News


Ohr Pharmaceutical Announces New Positive Anatomic and Visual Acuity Data on OHR-102 (Squalamine Eye Drops) IMPACT Study Presented at the 2014 American Academy of Ophthalmology Scientific Meeting

Read More »

Ohr Pharmaceutical Announces Successful End of Phase II Meeting With the FDA on Squalamine Eye Drops (OHR-102) in Wet AMD

Read More »
View All News